BioTelemetry, Inc. (NASDAQ: BEAT) received the Food and Drug Administration's approval for its next generation Mobile Cardiac Outpatient Telemetry device, the MCOT Patch. According to the company, the ...
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a ...
Shares ofBioTelemetry(NASDAQ: BEAT), a medical device company focused primarily on mobile cardiac monitoring, are up more than 16% as of 11:45 a.m. EDT on Wednesday. The huge jump is attributable to ...
As an initial remote monitoring diagnostic approach, Philips BioTel Heart MCOT detected 4.6 times more patients with atrial fibrillation compared to implantable loop recorder alone Almost eight times ...
Shares jump on the news that a major insurance company has decided to offer coverage on mobile cardiac telemetry devices. BioTelemetry is on a roll this year. The company's revenue and profits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback